My Size Inc
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
MYSZ$0.69-5.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
U.S. dollars in thousands
| Year ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Cash flows from operating activities: | ||
| Net loss | (6,380) | (8,310) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation | 27 | 38 |
| Change in operating lease right-of-use asset | 137 | 135 |
| Amortization of intangible assets | 302 | 155 |
| foreign exchange differences | (99) | (23) |
| Change in liabilities to related parties | (93) | 635 |
| Interest on long term liabilities | 57 | 10 |
| Interest paid | (23) | (10) |
| Revaluation of investment in marketable securities | 41 | 62 |
| Deferred tax benefits | (328) | (36) |
| Change in Investment in JV | 71 | - |
| Stock based compensation | 453 | 774 |
| Change in inventory | (1,839) | (219) |
| Impairment of goodwill | 671 | - |
| Change in account receivables | 1,200 | (1,863) |
| Changes in operating lease liabilities | (115) | (142) |
| Change in other receivables and prepaid expenses | (84) | 184 |
| Change in trade payables | (306) | 1,315 |
| Change in other payables | 202 | 5 |
| Net cash used in operating activities | (6,106) | (7,290) |
| Cash flows from investing activities: | ||
| Acquisition of a subsidiary, net of cash acquired | - | (767) |
| investing in other receivable | - | (100) |
| Investment in equity accounted investee | - | (99) |
| Purchase of property and equipment | (7) | (27) |
| Net cash (used in) provided by investing activities | (7) | (993) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of shares, net of issuance costs | 6,258 | - |
| Repayment of loans | (124) | (67) |
| Net cash (used in) provided by financing activities | 6,134 | (67) |
| Effect of exchange rate fluctuations on cash and cash equivalents | (120) | (230) |
| Change in cash and cash equivalents and restricted cash | (99) | (8,580) |
| Cash and cash equivalents and restricted cash at the beginning of the year | 2,363 | 10,943 |
| Cash and cash equivalents and restricted cash at the end of the year | 2,264 | 2,363 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.